Acadia Healthcare Company, Inc.
NASDAQ:ACHC · NASDAQ Global Select
+$1.14 today
Vol 2.78M · Avg 2.82M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-56.6%
avg -5.0%
ROIC
7.7%
avg 5.8%
ROA
-20.0%
avg -1.1%
Analysis
ROIC is currently the strongest return metric at 7.7% versus its period average of 5.8%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Brian Farley | Executive Vice President, General Counsel & Secretary | $1.06M | — | 56 | $139,122.00 | 0.15% |
David Duckworth | Interim Chief Financial Officer | $989,243.00 | — | 46 | $26,358.00 | 0.03% |
Tim Sides | Senior Vice President of Operations Finance | $856,724.00 | — | 48 | $30,661.00 | 0.03% |
Todd S. Young | Chief Financial Officer | $541,875.00 | — | 54 | $107,244.00 | 0.12% |
Debra K. Osteen | Chief Executive Officer & Director | $99,500.00 | — | 70 | $1.13M | 1.22% |
Jeffrey Woods | Operations Group President | — | — | — | — | — |
Patrick Thomas Feeley | Senior Vice President of Investor Relations | — | — | — | $47,511.00 | 0.05% |
Steve Quigley | Group President of Specialty Division | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +48.9% | +1.5% (14yr)1 analysts |
| Revenue | N/A | N/A | +63.9% | +6.2% (14yr)3 analysts |
| Net Income | N/A | N/A | +80.3% | +3.6% (14yr)3 analysts |
| EBIT | N/A | N/A | +65.5% | -4.3% (14yr)3 analysts |
Analysis
Recent growth has been strongest in Net Income at +80.3% over three years. Forward estimates point to Revenue at +6.2% (14yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
LifeStance Health Group, Inc.
NASDAQ:LFST
$3.42B
Brookdale Senior Living Inc.
NYSE:BKD
$3.26B
National HealthCare Corporation
AMEX:NHC
$3.02B
Select Medical Holdings Corporation
NYSE:SEM
$2.05B
Astrana Health, Inc.
NASDAQ:ASTH
$1.94B
Pediatrix Medical Group, Inc.
NYSE:MD
$1.89B
Addus HomeCare Corporation
NASDAQ:ADUS
$1.76B
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
$1.67B
Ardent Health Partners, LLC
NYSE:ARDT
$1.29B
QuidelOrtho Corporation
NASDAQ:QDEL
$904.53M
Who manages ACHC?
Acadia Healthcare Company, Inc. (ACHC) lists 8 active executives. The top listed executive is Jeffrey Woods, Operations Group President.
Are ACHC insiders buying or selling?
Recent insider activity shows net selling of $51.08M.
Explore More
Continue the stock analysis
Jump to another research area for this company.